A recent study explored the combination of CDK4 inhibitors and radiotherapy on CCA cells and reported that palbociclib affected the kinetics of DNA repair and enhanced the radiation sensitivity of hepatocellular carcinoma and CCA cells. This evidence concerns the gene CDK4 and cholangiocarcinoma.